Navigation Links
ATCC Announces Creation of Biomaterial Contributor Network
Date:8/27/2013

Manassas, VA (PRWEB) August 27, 2013

ATCC, the premier global biological materials resource and standards organization, announces material deposit agreements with over 30 leading public and private institutions. These institutions will have the option to participate in the new Biomaterial Contributor Network (BCN), and make important research materials available to the research community. ATCC will coordinate with Technology Transfer Offices at each institution to create a simple, streamlined process for adding new microbial strains and cell lines to the ATCC collection. Many of the participants will have an opportunity to receive a share of the revenue from the sale and licensing of materials developed at their institutions. Over 225 unique biological materials are deposited under these agreements to date, with most available to both contributors and others as determined jointly by ATCC and the institution.

“Since 1925, ATCC has set the standard for providing the largest and most diverse collection of authenticated biological materials to the scientific community. The Network enables Contributors to create a lasting impact on science around the globe,” said Dr. Raymond Cypess, CEO of ATCC. “These agreements reinforce ATCC’s Mission to distribute scientifically valuable, authenticated materials, while recognizing the shared financial benefit with participating institutions,” said Matt Klusas, Senior Director of Corporate Development at ATCC.

Government agencies with agreements include the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and the US Department of Agriculture - Agricultural Research Service (USDA-ARS). Academic institutions with agreements include but are not limited to Albert Einstein College of Medicine of Yeshiva University, Baylor College of Medicine, Colorado State University, Fred Hutchinson Cancer Research Center, George Mason University, Johns Hopkins University School of Medicine, King’s College London, the Massachusetts Institute of Technology (MIT), Michigan State University, National University of Singapore, Northwestern University, The Pennsylvania State University, Stanford University, University of British Columbia, several campuses of the University of California (Berkeley, Irvine, Riverside and San Francisco), University of Florida, University of Illinois at Urbana-Champaign, University of Maryland, University of North Carolina at Chapel Hill, the University of Toronto, University of Virginia, Virginia Tech, and Wake Forest University.

For more information about the ATCC Biomaterial Contributor Network, please visit http://www.atcc.org/bcn.

About ATCC
ATCC is a non-profit mission driven growth business providing quality products and innovative solutions through an organization built on integrity, expertise, and customer centricity. ATCC’s portfolio includes the world’s largest and most diverse collection of human, animal and plant cell lines, molecular genomic tools, microorganisms and bio products serving the scientific community. ATCC’s customers include global academic and government institutions, translational laboratories, pharmaceutical companies, food testing and forensics laboratories, and global public health laboratories. ATCC’s formal mission is to acquire, authenticate, preserve, develop and distribute biological materials, information, technology, intellectual property and standards for the advancement and application of scientific knowledge.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11061811.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):